Drugmakers are introducing discounts and lower-cost options for consumers who have to pay for GLP-1 drugs out of pocket. News outlets look at the trend in pricing for drugs like Wegovy and Zepbound.

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs ... medications was on the first list of 10 drugs up for price negotiation ...

SANTA ROSA COUNTY, Fla. -- A judge set bond Thursday for the three people charged in the Pace Pharmacy prescription drug trafficking case. Here is the amount for each: 54-year-old Stephen Burklow ...

CenterWell Specialty Pharmacy supports patients who apply for assistance programs to help defray the cost of specialty drugs for those in need. Winners of the MMIT Specialty Pharmacy Patient ...

Pharmaceutical experts say the executive order will have no immediate impact on how much people pay at the pharmacy ... requested drug discounts could range for 59% to 80% from list prices.

Rite Aid added 68 more locations to its list of closures in a May 9 filing ... In the meantime, customers will be able to access pharmacy services and the company said in a news release that ...

ignoring the fact that health care and pharmacy drug reform has been a pillar of the progressive platform in recent years (see: Representative Alexandria Ocasio-Cortez’s “Medicare for All ...

NEW YORK (Reuters) -President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices ... operate pharmacy benefit managers Caremark, Optum Rx ...

Supplements And Featured PublicationsConference Brief: Asembia’s AXS25 Summit: A Special Report on Specialty Pharmacy Specialty drugs are increasingly entering general medicine. Experts at Asembia’s ...

US Judge Sides With FDA's Removal of Lilly's Weight Loss Drug From Shortage List By Patrick Wingrove (Reuters) -A U.S. federal judge has sided with a U.S. regulator's decision last year to take ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s (LLY.N), opens new tab blockbuster weight loss and diabetes drugs Zepbound and Mounjaro off a list ...

May 7 (Reuters) - U.S. drug distributor Cencora (COR.N), opens new tab raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.